Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
D Ferguson, BN Finck
Abstract
Brief Summary: This article reviews the results of clinical trials for modulators of glucagon-like peptide-1 (GLP1) activity, insulin-sensitizing thiazolidinediones, and inhibitors of the sodium-glucose cotransporter 2 (SGLT2) for the treatment of NAFLD and type 2 diabetes mellitus.
Topics & Concepts
Type 2 Diabetes MellitusMedicineDiabetes mellitusInsulinType 2 diabetesClinical trialInternal medicineGlucagon-like peptide-1EndocrinologyPharmacologyDiet, Metabolism, and DiseaseLiver Disease Diagnosis and TreatmentDiabetes Treatment and Management